APA (7th ed.) Citation

XY, Y., L, X., Y, C., Y, Z., Y, D., MC, G., . . . YT, G. (2022). Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial. Frontiers in neurology, 13, 860083. https://doi.org/10.3389/fneur.2022.860083

Chicago Style (17th ed.) Citation

XY, Yao, et al. "Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial." Frontiers in Neurology 13 (2022): 860083. https://doi.org/10.3389/fneur.2022.860083.

MLA (9th ed.) Citation

XY, Yao, et al. "Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial." Frontiers in Neurology, vol. 13, 2022, p. 860083, https://doi.org/10.3389/fneur.2022.860083.